Angiotensin-receptor blockade, cancer, and concerns

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2010-09, Vol.11 (9), p.819-819
Hauptverfasser:	Meredith, Peter A, McInnes, Gordon T
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin II Type 1 Receptor Blockers - adverse effects Clinical Trials as Topic Hematology, Oncology and Palliative Medicine Humans Meta-Analysis as Topic Neoplasms - chemically induced Research Design
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	819
container_issue	9
container_start_page	819
container_title	The lancet oncology
container_volume	11
creator	Meredith, Peter A McInnes, Gordon T
description
doi_str_mv	10.1016/S1470-2045(10)70163-7
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754002600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1470204510701637</els_id><sourcerecordid>754002600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-f991ec7ff313162eff2dada4865da9dd12a102d377ad7ae4e80f06e8ffeed1fe3</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMobk5_gtI7FVY9ST_S3Qhj-AUDL9TrkCUn0q1LZ9IK-_em7fQqh5fn5E0eQi4p3FGg-f07TTnEDNLshsItD1ES8yMyDnEaZ2lRHPfzgIzImfdrAMopZKdkxKAIPOdjksztV1k3aH1pY4cKd03tolVVq43UOI2UtArdNJJWR6ruZuvPyYmRlceLwzkhn0-PH4uXePn2_LqYL2OV5EkTm9mMouLGJDShOUNjmJZapkWeaTnTmjJJgenwDKm5xBQLMJBjYQyipgaTCbke7t25-rtF34ht6RVWlbRYt17wLAVgOUAgs4FUrvbeoRE7V26l2wsKotMlel2ic9FFvS7Bw97VoaFdbVH_b_35CcDDAGD450-JTqiqtKWS1Qb36Nd162xQIKjwTMDQ0pVQ6Ct48guBL3qJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754002600</pqid></control><display><type>article</type><title>Angiotensin-receptor blockade, cancer, and concerns</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Meredith, Peter A ; McInnes, Gordon T</creator><creatorcontrib>Meredith, Peter A ; McInnes, Gordon T</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(10)70163-7</identifier><identifier>PMID: 20816377</identifier><language>eng</language><publisher>England</publisher><subject>Angiotensin II Type 1 Receptor Blockers - adverse effects ; Clinical Trials as Topic ; Hematology, Oncology and Palliative Medicine ; Humans ; Meta-Analysis as Topic ; Neoplasms - chemically induced ; Research Design</subject><ispartof>The lancet oncology, 2010-09, Vol.11 (9), p.819-819</ispartof><rights>Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-f991ec7ff313162eff2dada4865da9dd12a102d377ad7ae4e80f06e8ffeed1fe3</citedby><cites>FETCH-LOGICAL-c363t-f991ec7ff313162eff2dada4865da9dd12a102d377ad7ae4e80f06e8ffeed1fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20816377$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meredith, Peter A</creatorcontrib><creatorcontrib>McInnes, Gordon T</creatorcontrib><title>Angiotensin-receptor blockade, cancer, and concerns</title><title>The lancet oncology</title><addtitle>Lancet Oncol</addtitle><subject>Angiotensin II Type 1 Receptor Blockers - adverse effects</subject><subject>Clinical Trials as Topic</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Meta-Analysis as Topic</subject><subject>Neoplasms - chemically induced</subject><subject>Research Design</subject><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMobk5_gtI7FVY9ST_S3Qhj-AUDL9TrkCUn0q1LZ9IK-_em7fQqh5fn5E0eQi4p3FGg-f07TTnEDNLshsItD1ES8yMyDnEaZ2lRHPfzgIzImfdrAMopZKdkxKAIPOdjksztV1k3aH1pY4cKd03tolVVq43UOI2UtArdNJJWR6ruZuvPyYmRlceLwzkhn0-PH4uXePn2_LqYL2OV5EkTm9mMouLGJDShOUNjmJZapkWeaTnTmjJJgenwDKm5xBQLMJBjYQyipgaTCbke7t25-rtF34ht6RVWlbRYt17wLAVgOUAgs4FUrvbeoRE7V26l2wsKotMlel2ic9FFvS7Bw97VoaFdbVH_b_35CcDDAGD450-JTqiqtKWS1Qb36Nd162xQIKjwTMDQ0pVQ6Ct48guBL3qJ</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Meredith, Peter A</creator><creator>McInnes, Gordon T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100901</creationdate><title>Angiotensin-receptor blockade, cancer, and concerns</title><author>Meredith, Peter A ; McInnes, Gordon T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-f991ec7ff313162eff2dada4865da9dd12a102d377ad7ae4e80f06e8ffeed1fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Angiotensin II Type 1 Receptor Blockers - adverse effects</topic><topic>Clinical Trials as Topic</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Meta-Analysis as Topic</topic><topic>Neoplasms - chemically induced</topic><topic>Research Design</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meredith, Peter A</creatorcontrib><creatorcontrib>McInnes, Gordon T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meredith, Peter A</au><au>McInnes, Gordon T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin-receptor blockade, cancer, and concerns</atitle><jtitle>The lancet oncology</jtitle><addtitle>Lancet Oncol</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>11</volume><issue>9</issue><spage>819</spage><epage>819</epage><pages>819-819</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><cop>England</cop><pmid>20816377</pmid><doi>10.1016/S1470-2045(10)70163-7</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1470-2045
ispartof	The lancet oncology, 2010-09, Vol.11 (9), p.819-819
issn	1470-2045 1474-5488
language	eng
recordid	cdi_proquest_miscellaneous_754002600
source	MEDLINE; Elsevier ScienceDirect Journals
subjects	Angiotensin II Type 1 Receptor Blockers - adverse effects Clinical Trials as Topic Hematology, Oncology and Palliative Medicine Humans Meta-Analysis as Topic Neoplasms - chemically induced Research Design
title	Angiotensin-receptor blockade, cancer, and concerns
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T07%3A08%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin-receptor%20blockade,%20cancer,%20and%20concerns&rft.jtitle=The%20lancet%20oncology&rft.au=Meredith,%20Peter%20A&rft.date=2010-09-01&rft.volume=11&rft.issue=9&rft.spage=819&rft.epage=819&rft.pages=819-819&rft.issn=1470-2045&rft.eissn=1474-5488&rft_id=info:doi/10.1016/S1470-2045(10)70163-7&rft_dat=%3Cproquest_cross%3E754002600%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=754002600&rft_id=info:pmid/20816377&rft_els_id=1_s2_0_S1470204510701637&rfr_iscdi=true